Business & regional news

Month Year

Month Year

Sep 16, 2025

Extended use of MiniMed™ 780G system demonstrates increased trust in automation of insulin delivery and sustained glycemic improvement

After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.
- Diabetes
Sep 11, 2025

Medtronic to showcase MiniMed™ 780G system data across diverse patient populations at the European Association for the Study of Diabetes (EASD) 61st Annual Meeting
- Diabetes
Sep 9, 2025

Medtronic Introduces Evolut™ FX+ in India — A Move Forward in TAVI Therapy for Aortic Stenosis
- Asia Pacific
Sep 2, 2025

Medtronic receives approval for Symplicity Spyral™ Renal Denervation System in Japan

Japan is now the 77th country to receive regulatory approval for the Symplicity Spyral Renal Denervation System
- Coronary and Renal Denervation
Sep 2, 2025

Compelling data at ESC Congress 2025 reinforce safety and performance of the Medtronic OmniaSecure™ defibrillation lead, including in the left bundle branch area

The upcoming U.S. launch of the small-diameter OmniaSecure defibrillation lead will introduce the first FDA-approved lead for both adults and adolescent pediatric patients
- Cardiac Rhythm Management

Show per page